MedTrace Logo

Proton Therapy for Early Stage Breast Cancer

NCT00614172 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2023-09-21

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine if partial breast proton therapy is effective treatment for early stage breast cancer following lumpectomy.

Conditions

Interventions

RADIATION

Proton radiation therapy

Proton radiotherapy will start 2-4 weeks following surgical excision. The treatment area will include the lumpectomy site with an additional margin. Daily proton therapy will be given as an out-patient over a two week coarse.

Sponsors & Collaborators

  • Loma Linda University

    lead OTHER

Principal Investigators

  • David A. Bush, MD · Loma Linda University Department of Radiation Medicine

  • Jerry D. Slater, MD · Loma Linda University Department of Radiation Medicine

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-02-29
Primary Completion
2020-05-12
Completion
2020-05-12
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00614172 on ClinicalTrials.gov